Search

everythinglearnresearchcommunity

for

Search:↓

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Aggressive treatment in young patients with certain drug reactions may lead to multiple autoimmune diseases later.

Some patients on anti-TNF drugs experience a type of hair loss called TAIAPA.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Accurate diagnosis and zinc supplements can improve life quality in acrodermatitis enteropathica, even with normal zinc levels.

IL-1 blockade is effective for treating SURF, and personalized treatment is needed.

Adalimumab helped control a child's severe eye disease when other treatments failed.

A thorough, team-based approach and clear communication improve outcomes in complex neuropsychiatric lupus cases.

An 84-year-old man developed severe anemia after his first COVID-19 vaccine shot, improved with treatment, and was advised against a second dose.

Candida antigen is an effective and promising treatment for alopecia areata.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Denosumab, a bone loss treatment, may cause hair loss and skin reactions due to immune system effects.

The androgen receptor gene doesn't affect women with recurrent spontaneous abortions, but having a mutant genotype might protect against it.

Higher inflammation markers are linked to more severe alopecia areata.

Anti-Ku-positive patients often have muscle weakness and autophagy plays a key role in their condition.

There is no causal relationship between androgenetic alopecia and serum uric acid.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

RXR-alpha is strongly expressed in both normal and psoriatic skin and may help in skin cell differentiation and hair growth.

Daclizumab may cause psoriasis-like skin problems in multiple sclerosis patients.

Timely treatment with antibiotics and antiretrovirals can significantly improve health in HIV patients with syphilis.

Inflammation damages sweat ducts, causing sweat gland injury.

Belimumab may cause hair loss in lupus patients.

Upadacitinib improved multiple immune-related conditions in one patient.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

JAK inhibitors may help improve symptoms in adults with APECED.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

AE can have varied symptoms and genetic causes, but zinc therapy helps.

Abrocitinib may help treat alopecia areata effectively with mild side effects.